KRAS and neoplasm: To further investigate the different abilities of oncogenic KRAS G12C and KRAS G12D to initiate lung tumors and drive their growth, we explored the distribution of sgInert tumor sizes (Fig. 1J–L and Supplementary Fig. 3E–G).